The cost of outpatient versus inpatient total hip arthroplasty: a randomized trial

Bryn O Zomar1, Jacquelyn D Marsh2, Dianne M Bryant1

  • 1From the Faculty of Health Sciences, Western University, London, Ont. (Zomar, Marsh, Bryant); the Bone and Joint Institute, Western University, London, Ont. (Zomar, Marsh, Bryant, Lanting); the Division of Orthopaedic Surgery, London Health Sciences Centre, London, Ont. (Lanting); and the Schulich School of Medicine & Dentistry, Western University, London Ont. (Lanting).

Insights

Outpatient total hip arthroplasty (THA) may reduce healthcare costs. This study found outpatient THA to be more cost-effective than inpatient procedures, with similar adverse event rates.

Area of Science:

  • Orthopedic Surgery
  • Health Economics

Background:

  • Rising costs of total hip arthroplasty (THA) necessitate exploring cost-saving strategies.
  • Outpatient THA, involving same-day discharge, is a potential approach to mitigate these expenses.

Purpose of the Study:

  • To compare the economic impact of outpatient THA versus traditional inpatient THA.

Main Methods:

  • A preliminary analysis of a randomized controlled trial involving primary THA via direct anterior approach.
  • Participants were randomized to same-day or 1-day post-surgery discharge.
  • Cost and patient-reported outcome measures (WOMAC) were assessed at multiple time points.

Main Results:

  • The study included 115 participants; adverse event rates were comparable between outpatient and inpatient groups.
  • Outpatient THA demonstrated lower costs from both healthcare payer and societal perspectives.
  • While WOMAC scores were slightly higher in the outpatient group at 12 weeks, the cost savings were significant.

Conclusions:

  • Outpatient THA appears to be a cost-saving alternative to inpatient THA.
  • Further research with larger sample sizes is recommended to refine cost estimates.
Abstract

Related Concept Videos